To include your compound in the COVID-19 Resource Center, submit it here.

Med BioGene, Precision Therapeutics, Signal Genetics deal

Med BioGene said it accepted an amended offer from Precision to license exclusive, worldwide

Read the full 144 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE